Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sifan Yu

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Iscience|May 28, 2026
Harnessing artificial intelligence for pediatric health: Current trends and future opportunitiesJialin Wu, Bonan Chen, Kate Ching-Ching Chan, et al.
Molecular Therapy. Nucleic Acids|December 11, 2023
A bimolecular modification strategy for developing long-lasting bone anabolic aptamerHuarui Zhang, Sifan Yu, Shuaijian Ni, et al.
Cell & Bioscience|February 1, 2025
Classifications of triple-negative breast cancer: insights and current therapeutic approachesZiqi Chen, Yumeng Liu, Minchuan Lyu, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Cancer Science|April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosisTianxiao Xu, Meng Ma, Zhihong Chi, et al.
Oncology Letters|February 14, 2018
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanomaHuan Tang, Yan Kong, Lu Si, et al.
Cancer Letters|July 5, 2024
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapyYuan Ma, Huarui Zhang, Xinyang Shen, et al.
Human Pathology|February 17, 2018
Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanomaTianxiao Xu, Meng Ma, Jie Dai, et al.
Biochemical Pharmacology|July 22, 2023
The role of sclerostin in lipid and glucose metabolism disordersHewen Jiang, Dijie Li, Ying Han, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Iscience|May 28, 2026
Harnessing artificial intelligence for pediatric health: Current trends and future opportunitiesJialin Wu, Bonan Chen, Kate Ching-Ching Chan, et al.
Molecular Therapy. Nucleic Acids|December 11, 2023
A bimolecular modification strategy for developing long-lasting bone anabolic aptamerHuarui Zhang, Sifan Yu, Shuaijian Ni, et al.
Cell & Bioscience|February 1, 2025
Classifications of triple-negative breast cancer: insights and current therapeutic approachesZiqi Chen, Yumeng Liu, Minchuan Lyu, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2019
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapyHuan Tang, Meng Ma, Jie Dai, et al.
Cancer Science|April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosisTianxiao Xu, Meng Ma, Zhihong Chi, et al.
Oncology Letters|February 14, 2018
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanomaHuan Tang, Yan Kong, Lu Si, et al.
Cancer Letters|July 5, 2024
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapyYuan Ma, Huarui Zhang, Xinyang Shen, et al.
Human Pathology|February 17, 2018
Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanomaTianxiao Xu, Meng Ma, Jie Dai, et al.
Biochemical Pharmacology|July 22, 2023
The role of sclerostin in lipid and glucose metabolism disordersHewen Jiang, Dijie Li, Ying Han, et al.
Pageof 6